Biopharmaceutical firm Provention Bio has concluded patient enrolment in the Phase IIa PRINCE clinical trial of PRV6527 for the treatment...Read More...The post Provention Bio closes enrolment in PRINCE trial for Crohn&8217;s disease appeared first on ...
↧